Cargando…

Considerable use of Furazolidone in Iran

Detalles Bibliográficos
Autores principales:	Talebi Bezmin Abadi, Amin, Taghvaei, Tarang, Vaira, Dino
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995111/ https://www.ncbi.nlm.nih.gov/pubmed/20871207 http://dx.doi.org/10.4103/1319-3767.70631

Ejemplares similares

Furazolidone and Helicobacter pylori Treatment
por: Talebi Bezmin Abadi, Amin
Publicado: (2015)

Inefficiency of Rapid Urease Test for Confirmation of Helicobacter pylori
por: Abadi, Amin Talebi Bezmin, et al.
Publicado: (2011)

A Comparison between Moderate- and High-dose Furazolidone in Triple Regimens for Helicobacterpylori Eradication in Iran
por: Hosseini, Vahid, et al.
Publicado: (2014)

Comment on “Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Mix Infections of Helicobacter pylori: A Major Risk Factor Affecting Genotyping Studies
por: Talebi Bezmin Abadi, Amin
Publicado: (2014)

Updated Helicobacter pylori Management in 2015
por: Abadi, Amin Talebi Bezmin
Publicado: (2016)

Type 2 diabetes and Helicobacter pylori infection: Starting point for the reality?
por: Abadi, Amin Talebi Bezmin
Publicado: (2015)

Comment on “Characteristics and Risk Factors of Helicobacter pylori Associated Gastritis: A Prospective Cross-Sectional Study in Northeast Thailand”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Comment on “Bacteria in Cancer Therapy: Renaissance of an Old Concept”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Comment on “Lack of Association Found between Helicobacter pylori Infection and Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter Retrospective Study”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Fecal microbiota transplantation against irritable bowel syndrome? Rigorous randomized clinical trials are required
por: Abadi, Amin Talebi Bezmin
Publicado: (2017)

Call for global vaccine instead of Helicobacter pylori blind antibiotic therapy
por: Abadi, Amin Talebi Bezmin
Publicado: (2016)

Comment on “Helicobacter pylori Outer Membrane Protein 18 (Hp1125) Is Involved in Persistent Colonization by Evading Interferon-γ Signaling”
por: Talebi Bezmin Abadi, Amin, et al.
Publicado: (2015)

Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Kashani, Negin, et al.
Publicado: (2018)

Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”
por: Rahimi, Farid, et al.
Publicado: (2019)

Transparency and information sharing could help abate the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2020)

Furazolidone and Serotonin Syndrome: Is there any Association?
por: Karamanakos, Petros N
Publicado: (2008)

Comparison of quadruple and triple Furazolidone containing regimens on eradication of helicobacter pylori
por: Mokhtare, Marjan, et al.
Publicado: (2015)

Comment on “Gastric and colon metastasis from breast cancer: case report, review of the literature, and possible underlying mechanisms”
por: Talebi Bezmin Abadi, Amin
Publicado: (2017)

Resistance of Helicobacter pylori to furazolidone and levofloxacin: A viewpoint
por: Zamani, Mohammad, et al.
Publicado: (2017)

Emergence of the Delta Plus variant of SARS-CoV-2 in Iran
por: Rahimi, Farid, et al.
Publicado: (2021)

High Frequency of A2143G Mutation in Clarithromycin-Resistant Helicobacter pylori Isolates Recovered from Dyspeptic Patients in Iran
por: Abadi, Amin T., et al.
Publicado: (2011)

Simultaneous occurrence of seasonal influenza virus and SARS CoV-2 strains
por: Talebi Bezmin Abadi, A., et al.
Publicado: (2021)

Simultaneous occurrence of seasonal influenza virus and SARS CoV-2 strains
por: Talebi Bezmin Abadi, A., et al.
Publicado: (2021)

Diagnosis of Helicobacter pylori Using Invasive and Noninvasive Approaches
por: Talebi Bezmin Abadi, Amin
Publicado: (2018)

Strategies used by helicobacter pylori to establish persistent infection
por: Abadi, Amin Talebi Bezmin
Publicado: (2017)

Therapy of Helicobacter pylori: Present Medley and Future Prospective
por: Talebi Bezmin Abadi, Amin
Publicado: (2014)

Novel Idea: Virulence-Based Therapy Against Helicobacter pylori Infection (Smart Therapy)
por: Talebi Bezmin Abadi, Amin
Publicado: (2014)

The Helicobacter pylori dupA: A Novel Biomarker for Digestive Diseases
por: Talebi Bezmin Abadi, Amin
Publicado: (2014)

Helicobacter pylori: Emergence of a Superbug
por: Talebi Bezmin Abadi, Amin
Publicado: (2014)

Helicobacter pylori: A Beneficial Gastric Pathogen?
por: Talebi Bezmin Abadi, Amin
Publicado: (2014)

Helicobacter pylori and Gastric Cancer
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Comment on “Gastric cancer and family history”
por: Abadi, Amin Talebi Bezmin
Publicado: (2017)

Identification of Streptococcus gallolyticus in tumor samples of Iranian patients diagnosed with colorectal cancer
por: Kamali, Negin, et al.
Publicado: (2022)

Vonoprazan and Helicobacter pylori Treatment: A Lesson From Japan or a Limited Geographic Phenomenon?
por: Abadi, Amin Talebi Bezmin, et al.
Publicado: (2019)

Practical Strategies Against the Novel Coronavirus and COVID-19—the Imminent Global Threat
por: Rahimi, Farid, et al.
Publicado: (2020)

Challenges of managing the asymptomatic carriers of SARS-CoV-2
por: Rahimi, Farid, et al.
Publicado: (2020)

Tackling the COVID-19 Pandemic
por: Rahimi, Farid, et al.
Publicado: (2020)

Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2
por: Rahimi, Farid, et al.
Publicado: (2020)

Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01
por: Rahimi, Farid, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_69lkqgipjiv2vkb62j6pgjv0di